Complications result from persistent surface keratopathy, corneal scarring or thinning, keratoconus, cataracts, and symblepharon formation. Medical treatment with corticosteroids can further promote the development of cataracts, glaucoma, and secondary corneal infections. AKC may result in decreased vision or blindness from corneal complications. Proper prophylactic measures, prompt effective treatment of exacerbations, and well-timed elective surgical intervention can reduce the incidence of poor vision and blindness. Medicine is a constantly changing science and not all therapies are clearly established.
New research changes drug and treatment therapies daily.
However, as medical science is constantly changing and human error is always possible , the authors, editors, and publisher or any other party involved with the publication of this article do not warrant the information in this article is accurate or complete, nor are they responsible for omissions or errors in the article or for the results of using this information. The reader should confirm the information in this article from other sources prior to use. In particular, all drug doses, indications, and contraindications should be confirmed in the package insert. Atopic Please email us with any comments you have on our new chapter format.